<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04915911</url>
  </required_header>
  <id_info>
    <org_study_id>2020-1109</org_study_id>
    <nct_id>NCT04915911</nct_id>
  </id_info>
  <brief_title>Nutritional Status and Body Composition of Adult Patients With Crohn's Disease</brief_title>
  <official_title>A Multi-center, Cross-sectional Observational Study on Nutritional Status and Body Composition of Adult Patients With Crohn's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with Crohn's disease generally have nutritional risks and malnutrition. The&#xD;
      investigators will conduct a multicenter cross-sectional study to discover nutritional status&#xD;
      and body composition of Chinese adult patients with CD.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Several studies have found that the body composition of CD patients is related to disease and&#xD;
      therapies. Due to lack of a prospective multicenter cross-sectional observational study on&#xD;
      the nutritional status and body composition of adult patients with CD in China. Evaluating&#xD;
      the nutritional status and body composition of these patients can help formulate&#xD;
      individualized nutritional support strategies for adult CD patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2021</start_date>
  <completion_date type="Anticipated">May 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Appendicular skeletal mass index</measure>
    <time_frame>Within 48 hours of admission to hospital</time_frame>
    <description>Bioelectrical impedance analysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>Within 48 hours of admission to hospital</time_frame>
    <description>Especially body fat mass by bioelectrical impedance analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional risk screening</measure>
    <time_frame>Within 48 hours of admission to hospital</time_frame>
    <description>Detect the presence of undernutrition and the risk of developing undernutrition by Risk Screening 2002 (NRS-2002), when score≥3, the patient is nutritionally at-risk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional assessment</measure>
    <time_frame>Within 48 hours of admission to hospital</time_frame>
    <description>Detect malnourished individuals by the Subjective Global Assessment (SGA) , where A is well nourished and C is severely malnourished</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grip strength</measure>
    <time_frame>Within 48 hours of admission to hospital</time_frame>
    <description>Hand grip strength test</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Crohn Disease</condition>
  <arm_group>
    <arm_group_label>adult patients with Crohn's disease</arm_group_label>
    <description>multi-center cross-sectional study</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>cross-sectional study</intervention_name>
    <description>cross-sectional study</description>
    <arm_group_label>adult patients with Crohn's disease</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Chinese adult patients with Crohn's Disease&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years old;&#xD;
&#xD;
          -  diagnosis of CD;&#xD;
&#xD;
          -  Admission time &lt;48 hours;&#xD;
&#xD;
          -  Subject has voluntarily signed and dated an informed consent form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Emergency surgery for intestinal fistula or abdominal abscess;&#xD;
&#xD;
          -  Unstable vital signs or unstable hemodynamics;&#xD;
&#xD;
          -  Pregnant or lactating women;&#xD;
&#xD;
          -  Admission to hospital due to other critical illnesses (such as tumor, HIV, severe&#xD;
             infections requiring ventilator or CRRT treatment);&#xD;
&#xD;
          -  Dying patients whose life expectancy does not exceed 24 hours;&#xD;
&#xD;
          -  Severe liver insufficiency (liver function score 11-15 or total bilirubin&gt; 3mg/dL or&#xD;
             tissue biopsy diagnosed as liver cirrhosis, hepatic encephalopathy, portal&#xD;
             hypertension with history of gastrointestinal hemorrhage, etc.);&#xD;
&#xD;
          -  Severe renal insufficiency (creatinine value is 2 times higher than the upper limit of&#xD;
             normal);&#xD;
&#xD;
          -  Severe metabolic diseases (such as metabolic syndrome, hyperthyroidism, etc.);&#xD;
&#xD;
          -  Patients whose burn area exceeds 20% of the body surface area;&#xD;
&#xD;
          -  Immunodeficiency, autoimmune disease, or receiving immunosuppressive treatment for&#xD;
             diseases other than CD (such as organ transplantation, etc.);&#xD;
&#xD;
          -  Those who are not suitable for body composition analysis&#xD;
&#xD;
          -  Patients who have been selected for other clinical studies or have been selected for&#xD;
             this study;&#xD;
&#xD;
          -  Subjects are unwilling to participate in this study or refuse to sign informed&#xD;
             consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pianhong Zhang, MS</last_name>
    <phone>+86 8778 3852</phone>
    <email>zrlcyyzx@zju.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>2nd Affiliated Hospital, School of Medicine, Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310009</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pianhong Zhang, Ms</last_name>
      <phone>+86 87783852</phone>
      <email>zrlcyyzx@zju.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 11, 2021</study_first_submitted>
  <study_first_submitted_qc>May 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 7, 2021</study_first_posted>
  <last_update_submitted>July 14, 2021</last_update_submitted>
  <last_update_submitted_qc>July 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

